Device Authority adopts usage-based pricing to support KeyScaler expansion

Tern plc

Device Authority is moving KeyScaler to a usage-based pricing model, giving customers more flexibility as machine identity requirements expand across connected devices, operational technology and other non-human identities.

The change replaces the need to commit to fixed device volumes in advance. Instead, customers use credits based on the identity operations they perform, including provisioning identities, rotating credentials, enrolling certificates and adding vulnerability or software bill of materials data.

Fixed licensing can create problems when customers cannot accurately predict device volumes. Companies may pay for unused capacity if deployments are delayed or smaller than expected. If deployments grow faster than planned, they may need additional procurement or licensing before extending security controls.

Usage-based pricing reduces that friction. Customers can increase or reduce consumption in line with deployment activity without relying on long-term forecasts.

Device Authority is also making the full KeyScaler capability set available under the new model rather than requiring separate licence commitments for individual functions. This gives customers more freedom to test additional use cases and extend the platform into new parts of their device estate.

A customer could, for example, trial KeyScaler on a new product line or apply additional intelligence to an existing fleet without first renegotiating its licence structure. That may make it easier for Device Authority to expand within existing customer environments where adoption previously depended on additional budget or procurement decisions.

The model may also improve accessibility for organisations with smaller device estates. These customers can face the same security and compliance pressures as larger operators but may be less willing to make substantial upfront licensing commitments.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Search